Your browser doesn't support javascript.
loading
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma.
De Smedt, Renate; Peirs, Sofie; Morscio, Julie; Matthijssens, Filip; Roels, Juliette; Reunes, Lindy; Lintermans, Beatrice; Goossens, Steven; Lammens, Tim; Van Roy, Nadine; Touzart, Aurore; Jenni, Silvia; Tsai, Yi-Chien; Lovisa, Federica; Mussolin, Lara; Serafin, Valentina; Van Nieuwerburgh, Filip; Deforce, Dieter; Uyttebroeck, Anne; Tousseyn, Thomas; Burkhardt, Birgit; Klapper, Wolfram; De Moerloose, Barbara; Benoit, Yves; Macintyre, Elizabeth; Bourquin, Jean-Pierre; Basso, Giuseppe; Accordi, Benedetta; Bornhauser, Beat; Meijerink, Jules; Vandenberghe, Peter; Van Vlierberghe, Pieter.
Afiliación
  • De Smedt R; Department of Biomolecular Medicine, Ghent University, Belgium.
  • Peirs S; Cancer Research Institute Ghent (CRIG), Belgium.
  • Morscio J; Department of Biomolecular Medicine, Ghent University, Belgium.
  • Matthijssens F; Cancer Research Institute Ghent (CRIG), Belgium.
  • Roels J; Department of Biomolecular Medicine, Ghent University, Belgium.
  • Reunes L; Cancer Research Institute Ghent (CRIG), Belgium.
  • Lintermans B; Department of Biomolecular Medicine, Ghent University, Belgium.
  • Goossens S; Cancer Research Institute Ghent (CRIG), Belgium.
  • Lammens T; Department of Biomolecular Medicine, Ghent University, Belgium.
  • Van Roy N; Cancer Research Institute Ghent (CRIG), Belgium.
  • Touzart A; Diagnostic Sciences, Ghent University, Belgium.
  • Jenni S; Department of Biomolecular Medicine, Ghent University, Belgium.
  • Tsai YC; Cancer Research Institute Ghent (CRIG), Belgium.
  • Lovisa F; Department of Biomolecular Medicine, Ghent University, Belgium.
  • Mussolin L; Cancer Research Institute Ghent (CRIG), Belgium.
  • Serafin V; Department of Biomolecular Medicine, Ghent University, Belgium.
  • Van Nieuwerburgh F; Cancer Research Institute Ghent (CRIG), Belgium.
  • Deforce D; Molecular and Cellular Oncology Lab, Department for Biomedical Molecular Biology, Ghent University, Belgium.
  • Uyttebroeck A; Cancer Research Institute Ghent (CRIG), Belgium.
  • Tousseyn T; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Belgium.
  • Burkhardt B; Department of Biomolecular Medicine, Ghent University, Belgium.
  • Klapper W; Cancer Research Institute Ghent (CRIG), Belgium.
  • De Moerloose B; Department of Hematology, APHP-Hôpital Necker, Paris, France.
  • Benoit Y; Department of Oncology, and Children's Research Center, University Children's Hospital Zurich, Switzerland.
  • Macintyre E; Department of Oncology, and Children's Research Center, University Children's Hospital Zurich, Switzerland.
  • Bourquin JP; Department of Woman's and Child's Health, Hematology-Oncology Laboratory, Istituto di Ricerca Pediatrica (IRP) and University of Padova, Italy.
  • Basso G; Department of Woman's and Child's Health, Hematology-Oncology Laboratory, Istituto di Ricerca Pediatrica (IRP) and University of Padova, Italy.
  • Accordi B; Department of Woman's and Child's Health, Hematology-Oncology Laboratory, Istituto di Ricerca Pediatrica (IRP) and University of Padova, Italy.
  • Bornhauser B; Laboratory of Pharmaceutical Biotechnology, Ghent University, Belgium.
  • Meijerink J; Laboratory of Pharmaceutical Biotechnology, Ghent University, Belgium.
  • Vandenberghe P; Department of Pediatric Hematology-Oncology, University Hospitals Leuven, Belgium.
  • Van Vlierberghe P; Department of Oncology, KU Leuven, Belgium.
Haematologica ; 104(1): e17-e20, 2019 01.
Article en En | MEDLINE | ID: mdl-30076176

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Proteínas Proto-Oncogénicas c-pim-1 / Leucemia-Linfoma Linfoblástico de Células T Precursoras Límite: Humans Idioma: En Revista: Haematologica Año: 2019 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Proteínas Proto-Oncogénicas c-pim-1 / Leucemia-Linfoma Linfoblástico de Células T Precursoras Límite: Humans Idioma: En Revista: Haematologica Año: 2019 Tipo del documento: Article País de afiliación: Bélgica